MENU
+Compare
CERS
Stock ticker: NASDAQ
AS OF
Sep 3 closing price
Price
$1.31
Change
+$0.04 (+3.15%)
Capitalization
252.08M

CERS Cerus Corp Forecast, Technical & Fundamental Analysis

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety... Show more

CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CERS with price predictions
Sep 03, 2025

CERS's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for CERS turned positive on August 25, 2025. Looking at past instances where CERS's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 66 cases where CERS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 28, 2025. You may want to consider a long position or call options on CERS as a result. In of 109 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CERS advanced for three days, in of 237 cases, the price rose further within the following month. The odds of a continued upward trend are .

CERS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 10-day moving average for CERS crossed bearishly below the 50-day moving average on July 30, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CERS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CERS entered a downward trend on August 27, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.548) is normal, around the industry mean (60.010). P/E Ratio (0.000) is within average values for comparable stocks, (37.554). CERS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.664). CERS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (1.280) is also within normal values, averaging (80.939).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CERS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CERS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CERS is expected to report earnings to fall 11.00% to -2 cents per share on October 30

Cerus Corp CERS Stock Earnings Reports
Q3'25
Est.
$-0.03
Q2'25
Est.
$-0.03
Q1'25
Est.
$-0.04
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.01
The last earnings report on August 05 showed earnings per share of -2 cents, meeting the estimate of -2 cents. With 1.82M shares outstanding, the current market capitalization sits at 252.08M.
A.I. Advisor
published General Information

General Information

a developer of the INTERCEPT Blood System for platelets and plasma

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
1220 Concord Avenue
Phone
+1 925 288-6000
Employees
288
Web
https://www.cerus.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GALKF0.060.01
+14.75%
Galantas Gold Corp.
MHIVF0.09N/A
N/A
Invesque Inc.
MPZAF44.60N/A
N/A
Mips Ab
BEIGF15.95N/A
N/A
BeOne Medicines Ltd.
CRGGF2.48N/A
-0.20%
China Resources Gas Group Ltd

CERS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CERS has been loosely correlated with UTMD. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CERS jumps, then UTMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERS
1D Price
Change %
CERS100%
+3.15%
UTMD - CERS
45%
Loosely correlated
-0.68%
BLFS - CERS
45%
Loosely correlated
-1.18%
NNOX - CERS
44%
Loosely correlated
-0.79%
CLPT - CERS
44%
Loosely correlated
-1.73%
LAB - CERS
43%
Loosely correlated
+4.03%
More

Groups containing CERS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERS
1D Price
Change %
CERS100%
+3.15%
Medical/Nursing Services
industry (226 stocks)
55%
Loosely correlated
+0.12%
Health Services
industry (436 stocks)
36%
Loosely correlated
+0.02%